Bilateral anterior cerebral artery occlusion following CD19- and BCMA-targeted chimeric antigen receptor T-cell therapy for a myeloma patient

Chimeric antigen receptor T (CAR-T)-cell therapy is a promising treatment for relapsed/refractory multiple myeloma (RRMM). In our previous report, CD19- and BCMA-targeted CAR-T co-administration was associated with a high response rate. Although cytokine release syndrome (CRS) and neurotoxicity are...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-xia, Yu, Xian-qiu, Cao, Jiang, Lu, Yi-long, Luo, Ming, Lei, Fang, Tang, Yu, Fei, Xiao-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131494/
https://www.ncbi.nlm.nih.gov/pubmed/34009622
http://dx.doi.org/10.1007/s12185-021-03160-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131494/
https://www.ncbi.nlm.nih.gov/pubmed/34009622
http://dx.doi.org/10.1007/s12185-021-03160-4

Ejemplares similares